van der Bijl, Arie E <br/><br/>
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status.  [electronic resource] 

 -  Clinical rheumatology  Aug 2008 
 - 1021-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0770-3198 
<br/><br/><label>Standard No.: </label>10.1007/s10067-008-0866-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Antibodies--blood<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Arthritis, Rheumatoid--drug therapy<br/>Female<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Prospective Studies<br/>Treatment Failure<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors